Citius Oncology

1.89
+0.14
+8.00%
CTOR
 1.93 1.75 37.93万股总市值 1.48亿
 1.74 0.48% 69.39万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
用户头像
FelixW_粟
07-28 17:44  
The US Nuclear Regulatory Commission has approved a series of licensing and regulatory actions that will allow fuel loading at Holtec's plant.
Greg Bowman, Acting Director, Office of Nuclear Reactor Regulation (seated, left) and Kelly Trice, watched by NRC's Jamie...
3
用户头像
FelixW_粟
08-07 18:02  
Once again, the world is betting on nuclear power. The United States aims to quadruple its nuclear capacity by 2050, and more than 30 countries have pledged to triple global capacity by mid-century. China has more than 30 reactors under construction and in planning, and Franc...
用户头像
如梦令1980
06-13 09:56  
回复@见龙在田lyp: 你打错字了吧?你是不是想说甘肃武威“Thorium Molten Salt Reactor - Liquid Fuel 1” ,即“钍基熔盐堆 - 液态燃料1号”?
TMSR-LF1,这是个实验堆,目前已并网发电,主要目的是验证技术路线、积累运行经验、测试关键材料和设备。后续目标是建设实验/示范电站(如计划中的...
@如梦令1980 :$中国核电(SH601985)$ 中核引领:百万千瓦商用快堆
原子能院自主开发的 1 200 MWe 商用快堆,在 CFR600 的基础上将验证快堆的经济实用性。
商用快堆工程的实施,一方面在示范快堆基础上进一步积累大型快堆工程设计、建造及运行经验,提高钠冷快堆经济性,使其比投资与主流压水堆相比具有一...
2
用户头像
Citius Oncology(CTOR)
07-26 05:05  
$Citius Oncology(CTOR)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001213900-25-067797  Act: 34  Size: 6 KB 网页链接
用户头像
Citius Oncology(CTOR)
08-13 04:35  
$Citius Oncology(CTOR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-25-074992  Act: 34  Size: 2 MB 网页链接
用户头像
Citius Oncology(CTOR)
08-19 05:35  
$Citius Oncology(CTOR)$ 8-K Current report, item 8.01 Accession Number: 0001213900-25-078018  Act: 34  Size: 189 KB 网页链接
用户头像
Citius Oncology(CTOR)
08-08 05:05  
$Citius Oncology(CTOR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-25-073136  Size: 6 KB 网页链接
用户头像
Citius Oncology(CTOR)
06-28 05:05  
$Citius Oncology(CTOR)$ 8-K Current report, item 8.01 Accession Number: 0001213900-25-059084  Act: 34  Size: 187 KB 网页链接
用户头像
Citius Oncology(CTOR)
07-15 05:25  
$Citius Oncology(CTOR)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-25-063793  Act: 33  Size: 4 MB 网页链接
用户头像
Citius Oncology(CTOR)
07-14 20:35  
$Citius Oncology(CTOR)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-25-063483  Act: 33  Size: 5 MB 网页链接
用户头像
Citius Oncology(CTOR)
07-17 18:05  
$Citius Oncology(CTOR)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002269  Act: 33  Size: 1 KB 网页链接
用户头像
Citius Oncology(CTOR)
07-18 20:05  
$Citius Oncology(CTOR)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001213900-25-065334  Act: 34  Size: 1 MB 网页链接
用户头像
Citius Oncology(CTOR)
07-17 18:05  
$Citius Oncology(CTOR)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001213900-25-064848  Act: 33  Size: 1 MB 网页链接
用户头像
Citius Oncology(CTOR)
06-18 04:15  
$Citius Oncology(CTOR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-25-055182  Act: 34  Size: 251 KB 网页链接
用户头像
Citius Oncology(CTOR)
08-13 04:55  
$Citius Oncology(CTOR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-25-075014  Act: 34  Size: 274 KB 网页链接
用户头像
Citius Oncology(CTOR)
08-19 05:35  
$Citius Oncology(CTOR)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001213900-25-078016  Act: 33  Size: 301 KB 网页链接